UPLOAD Filing
Bone Biologics Corp
Date: July 1, 2025 · CIK: 0001419554 · Accession: 0000000000-25-006912
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288290
Letter
Re: Bone Biologics Corp Registration Statement on Form S-3 Filed June 24, 2025 File No. 333-288290 Dear Jeffrey Frelick:
July 1, 2025
Jeffrey Frelick Chief Executive Officer Bone Biologics Corp 2 Burlington Woods Drive, Suite 100 Burlington, MA 01803
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Alexander R. McClean, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 1, 2025 Jeffrey Frelick Chief Executive Officer Bone Biologics Corp 2 Burlington Woods Drive, Suite 100 Burlington, MA 01803 Re: Bone Biologics Corp Registration Statement on Form S-3 Filed June 24, 2025 File No. 333-288290 Dear Jeffrey Frelick: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Alexander R. McClean, Esq. </TEXT> </DOCUMENT>